IP Verse

Methods For Treating Or Preventing Asthma By Administering An Il 4r Antagonist - EP4011915

PATENT ANALYSIS

Patent Details

Grant Date
Nov 15, 2023
Company
REGENERON PHARMACEUTICALS, INC.
Oppositions

BOULT WADE TENNANT LLP

DR. H. ULRICH DORRIES

HAMPTON KNOWLES LIMITED

LUIGI, RUMI

MICHALSKI HUTTERMANN & PARTNER PATENTANWALTE MBB

SECERNA LLP

More patents of Regeneron Pharmaceuticals, Inc.

EP4011915

EP2967015

EP3384049

Want to monitor this patent?

Feel free to send us a message here and we will get back to you